Clinical Trials Directory

Trials / Completed

CompletedNCT02469285

The Effect of Pork With Modified Fat Composition and Berries on Plasma Fatty Acids and Fecal Compounds in Healthy Adults

The Effect of Pork With Modified Fatty Acid Composition on Plasma Lipids and Fatty Acids and the Effect of Pork and Berries on Fecal Compounds in Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
University of Helsinki · Academic / Other
Sex
All
Age
20 Years – 68 Years
Healthy volunteers
Accepted

Summary

High consumption of red meat is related to cardiovascular diseases. Red meat containing more unsaturated fat than normal red meat may have a beneficial impact on plasma lipid and fatty acid profile in humans. Furthermore, consumption of red meat and especially processed red meat is considered harmful to colon health. However, consumption of fruit and berries rich in antioxidants and flavonoids may provide protection when red meat is consumed. The study aims to answer whether the fatty acid profile of pork when modified towards more unsaturated fat will affect plasma fatty acids and lipids in adult volunteers. The effects of pork with a modified fatty acid content is compared with conventional pork with lower unsaturated fat content. Fatty acid composition of pork is modified by altering the composition of animal feed. The other arm of the study investigates the effects of consuming berries together with red meat on gut metabolism. The study focuses on how berries affect the formation of fecal compounds known to be related to high red meat consumption, such as N-nitroso compounds.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTModified porkPork with modified fatty acid composition
DIETARY_SUPPLEMENTPorkPork with normal fat composition
DIETARY_SUPPLEMENTPork and berriesPork with normal fat composition and Finnish berries

Timeline

Start date
2014-09-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2015-06-11
Last updated
2022-05-24

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT02469285. Inclusion in this directory is not an endorsement.